
Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides
Author(s) -
Leinys S Santos-Baez,
Henry N. Ginsberg
Publication year - 2021
Publication title -
current opinion in lipidology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.412
H-Index - 124
eISSN - 1473-6535
pISSN - 0957-9672
DOI - 10.1097/mol.0000000000000756
Subject(s) - fatty liver , nonalcoholic fatty liver disease , insulin resistance , metabolic syndrome , steatosis , disease , diabetes mellitus , triglyceride , type 2 diabetes , bioinformatics , obesity , medicine , biology , endocrinology , cholesterol
Nonalcoholic fatty liver disease (NAFLD) is defined as the abnormal accumulation of lipids in the liver, called hepatic steatosis, which occurs most often as a concomitant of the metabolic syndrome. Its incidence has surged significantly in recent decades concomitant with the obesity pandemic and increasing consumption of refined carbohydrates and saturated fats. This makes a review of the origins of NAFLD timely and relevant.